Document Detail

Durability of Rifaximin Response in Hepatic Encephalopathy.
MedLine Citation:
PMID:  22011586     Owner:  NLM     Status:  Publisher    
GOALS:: To evaluate the durability of the response to rifaximin for treatment of hepatic encephalopathy (HE). BACKGROUND:: The nonsystemic antibiotic rifaximin has been approved for maintenance of HE remission, and several studies have indicated the efficacy of rifaximin for acute HE; however, the duration of therapeutic response for >6 months remains unknown. STUDY:: Medical records of patients with cirrhosis who received rifaximin maintenance therapy for HE between January 2004 and May 2009 were reviewed. Model for end-stage liver disease (MELD) scores were obtained every 3 months during therapy. RESULTS:: Of 203 patients with HE (Conn score ≥2), 149 received rifaximin monotherapy (400 to 1600 mg/d) and 54 received rifaximin (600 to 1200 mg/d) and lactulose (90 mL/d) dual therapy. Maintenance of HE remission for 1 year occurred in 81% and 67% of patients who received rifaximin monotherapy and rifaximin and lactulose dual therapy, respectively. Patient populations with a baseline mean MELD score ≤20 had few overt HE events, suggesting increased response to rifaximin in these patients. CONCLUSIONS:: Rifaximin is effective for the management of HE in patients with cirrhosis, particularly in populations with MELD scores ≤20. Additional studies are needed to investigate the potential association between MELD scores and the efficacy of HE treatments.
Guy W Neff; Michael Jones; Taylor Broda; Mark Jonas; Ravinuthala Ravi; David Novick; Tiffany E Kaiser; Nyingi Kemmer
Related Documents :
21707826 - Analysis of t2 intensity by magnetic resonance imaging of deep gray matter nuclei in mu...
22129916 - Etanercept treatment in juvenile idiopathic arthritis: the polish registry.
21752066 - New anticoagulants: how to deal with treatment failure and bleeding complications.
25313946 - Low-dose acitretin in papillon-lefèvre syndrome: treatment and 1-year follow-up.
25434616 - Field experience with surgical castration with anaesthesia, analgesia, immunocastration...
16785836 - The role of cox-2 inhibitors in the treatment of postoperative pain.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-10-18
Journal Detail:
Title:  Journal of clinical gastroenterology     Volume:  -     ISSN:  1539-2031     ISO Abbreviation:  -     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-10-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7910017     Medline TA:  J Clin Gastroenterol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
*Tampa General Medical Group, Tampa, FL †Tri-State Gastroenterology Associates ‡University of Indianapolis, Indianapolis, IN §Greater Cincinnati Gastroenterology Associates, Cincinnati ∥Digestive Specialists, Inc, Dayton, OH.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Olanzapine and Benztropine as a Cause of Ischemic Colitis in a 27-year-old Man.
Next Document:  Chronic Idiopathic Constipation: More Than A Simple Colonic Transit Disorder.